Talphera TLPH
NASDAQ TLPH
$1.24 +0.02 (+1.64%)
At close: Sep 10, 2026 · 4:00 PM EDT

Talphera (TLPH) Net Shares Issued and Repurchased (2010 - 2026)

Talphera (TLPH) posted Net Shares Issued and Repurchased of $1.5 million for Q1 2026, up 57.71% on a QoQ basis from $919781.0 in Q4 2025, and up 18032.5% year-over-year from N/an in Q1 2025.

Analysis

Talphera (TLPH) Net Shares Issued and Repurchased (2010 - 2026) Analysis & Trends

Talphera has reported Net Shares Issued and Repurchased for 17 years, with the latest figure at $1.5 million in Q1 2026.

  • On a quarterly basis, Net Shares Issued and Repurchased rose 18032.5% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $1.5 million, a 18032.5% increase from a year earlier, with the FY2025 full-year figure at $919781.0, down 12.7% from the prior year.
  • Net Shares Issued and Repurchased was $1.5 million for Q1 2026 at Talphera, up from $919781.0 in the prior quarter.
  • The five-year high for Net Shares Issued and Repurchased was $2.1 million in Q1 2022, with the low at $8000.0 in Q1 2025.
  • Average Net Shares Issued and Repurchased over 5 years is $779606.9, with a median of $790348.0 recorded in 2024.
  • The sharpest annual moves came in 2025 and 2026: Net Shares Issued and Repurchased tumbled 98.99% in 2025, then jumped 18032.5% in 2026.
  • Over 5 years, Net Shares Issued and Repurchased stood at $117022.0 in 2022, then jumped by 146.9% to $288929.0 in 2023, then surged by 264.66% to $1.1 million in 2024, then declined by 12.7% to $919781.0 in 2025, then surged by 57.71% to $1.5 million in 2026.
  • The last three Net Shares Issued and Repurchased figures came in at $1.5 million (Q1 2026), $919781.0 (Q4 2025), and $8000.0 (Q1 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Talphera 92.90 Mn 92.90 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.45 Mn
Dec 31, 2025 919,781.00
Mar 31, 2025 8,000.00
Dec 31, 2024 1.05 Mn
Mar 31, 2024 790,348.00
Dec 31, 2023 288,929.00
Mar 31, 2023 264,520.00
Dec 31, 2022 117,022.00
Mar 31, 2022 2.12 Mn
Dec 31, 2021 2.67 Mn
Dec 31, 2020 1.82 Mn
Dec 31, 2019 2.06 Mn
Dec 31, 2018 3.55 Mn
Dec 31, 2017 3.01 Mn
Dec 31, 2016 1.89 Mn
Dec 31, 2015 997,099.00
Dec 31, 2014 2.51 Mn
Dec 31, 2013 1.96 Mn
Dec 31, 2012 1.21 Mn
Dec 31, 2011 514,958.00